NeoGenomics, Inc. (NEO)
NASDAQ: NEO · Real-Time Price · USD
16.51
-2.63 (-13.72%)
At close: Oct 6, 2026, 4:00 PM EDT
16.76
+0.26 (1.54%)
After-hours: Oct 6, 2026, 5:14 PM EDT
NeoGenomics Stock Forecast
Stock Price Forecast
According to 12 analysts polled by S&P Global, NeoGenomics stock has a consensus rating of "Buy" and an average price target of $21.15. The average 1-year stock price forecast is 28.14% higher than the current stock price, while the lowest is $16 (-3.06%) and the highest is $35 (+112.06%).
Price Target: $21.15 (+28.14%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for NeoGenomics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 6 | 6 | 6 | 7 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 4 | 4 | 4 | 4 | 4 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 12 | 12 | 12 | 12 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Buy Reiterates $19 → $22 | Buy | Reiterates | $19 → $22 | +33.29% | Oct 6, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $21 | Buy | Maintains | $21 | +27.23% | Oct 6, 2026 |
| William Blair | William Blair | Hold Maintains n/a | Hold | Maintains | n/a | n/a | Oct 6, 2026 |
| StoneX | StoneX | Buy Maintains $16 → $20 | Buy | Maintains | $16 → $20 | +21.18% | Oct 6, 2026 |
| BTIG | BTIG | Buy Upgrades $28 | Buy | Upgrades | $28 | +69.65% | Oct 6, 2026 |
Financial Forecast
Revenue This Year
804.69M
from 727.33M
Increased by 10.64%
Revenue Next Year
884.84M
from 804.69M
Increased by 9.96%
EPS This Year
0.18
from 0.12
Increased by 53.79%
EPS Next Year
0.34
from 0.18
Increased by 82.75%
EPS and Forward PE are based on non-GAAP adjusted numbers.